✦ LIBER ✦

Age-related impairment of tumor-associated lymphocytotoxicity in patients with colonic adenocarcinoma

✍ Scribed by M. H. Goldrosen; D. Rohrdanz; B. Sabatino; G. P. Burns; E. D. Holyoke

Book ID: 112787698
Publisher: Springer
Year: 1977
Tongue: English
Weight: 312 KB
Volume: 20
Category: Article
ISSN: 0012-3706
DOI: 10.1007/bf02586618

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impaired lymphocyte blastogenic response

Impaired lymphocyte blastogenic response in patients with colon adenocarcinoma: Effects of disease and age

✍ Dr. Martin H. Goldrosen; Tin Han; Okhee Jung; James Smolev; E. Douglas Holyoke 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

## Abstract The in vitro blastogenic response of 76 patients with colon adenocarcinoma and 29 age‐matched normal healthy volunteers was compared. An age‐related decline in cellular immunocompetence was observed in both the patient and control group. Within each age interval, the patients' blastogen

Tumor associated lymphocyte cytotoxicity

Tumor associated lymphocyte cytotoxicity correlated with stage of disease in patients with colon adenocarcinoma: A preliminary report

✍ Patrick J. Gannon; E.Douglas Holyoke; Martin H. Goldrosen 📂 Article 📅 1978 🏛 Elsevier Science ⚖ 443 KB

Polyamine levels in healthy and tumor ti

Polyamine levels in healthy and tumor tissues of patients with colon adenocarcinoma

✍ Aldo Becciolini; Sauro Porciani; Aldo Lanini; Manuela Balzi; Luca Cionini; Luca 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 611 KB

Tumor-associated antigen in patients wit

Tumor-associated antigen in patients with carcinoma of the colon

✍ P.Lo Gerfo; F.Lo Gerfo; F. Herter; H.G. Barker; H.J. Hansen 📂 Article 📅 1972 🏛 Elsevier Science 🌐 English ⚖ 551 KB

Tumor location and patient characteristi

Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes

✍ Kari Hemminki; Irene Santi; Marianne Weires; Hauke Thomsen; Jan Sundquist; Justo 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 196 KB

Specific active immunotherapy in patient

Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial

✍ Ariel Hollinshead; E. George Elias; Myron Arlen; Barbara Buda; Maria Mosley; Jos 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

Twenty-two patients received specific active immunotherapy (TAA vaccine once per month for 3 months), with the duration of follow-up, as of July 1984, ranging from 3 months to 36 months (median, 21 months). Of these, seven had Dukes Bz, seven had Dukes C, and eight had Dukes D lesions. All received